Australia’s decision last year to reverse-switch codeine from a non-prescription to a prescription-only medicine has been “vindicated” by data showing a 50% drop in the drug’s supply, according to the Australian Medical Association.
“The Therapeutic Goods Administration and the Federal Government held firm in the face of great pressure from pharmacy lobby groups,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?